# Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

> **NCT06122974** · NA · NOT_YET_RECRUITING · sponsor: **ReFlow Medical, Inc.** · enrollment: 518 (estimated)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **DEVICE:** Drug Eluting Temporary Spur Stent System
- **DEVICE:** Percutaneous Transluminal Balloon Angioplasty

## Key facts

- **NCT ID:** NCT06122974
- **Lead sponsor:** ReFlow Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2032-06
- **Final completion:** 2037-12
- **Target enrollment:** 518 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06122974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06122974, "Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06122974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*